We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Brain Stimulation Reduces Spasticity after Spinal Cord Injury

By HospiMedica International staff writers
Posted on 03 Jul 2017
Print article
A new study claims that excitatory intermittent theta burst stimulation (iTBS) is successful in reducing spasticity in patients with spinal cord injury (SCI).

Researchers at Paracelsus Medical University (Salzburg, Austria), the University of Verona (Italy), and other institutions conducted a study to investigate if iTBS, a safe, non-invasive and well-tolerated protocol of excitatory repetitive transcranial magnetic stimulation (rTMS), is effective in modulating spasticity. The study included ten subjects with incomplete cervical or thoracic SCI. Five patients received 10 days of real or iTBS, and the remaining five received sham treatment. After two months, the sham group was switched to real iTBS and the study continued.

The researchers measured motor-evoked potentials (MEP) in the soleus (calf muscle), during magnetic stimulation over the most responsive area of the scalp. M-wave and H reflexes, which are measures of muscle contractions due to stimulation of the tibial nerve, were assessed for each subject, and an H/M amplitude ratio was determined. Modified Ashworth Scale (MAS) and the Spinal Cord Injury Assessment Tool for Spasticity (SCAT) were also compared before and after the stimulation protocols.

The results showed that patients receiving real iTBS showed significant increased resting and active MEPs amplitude and a significant reduction of the H/M amplitude ratio. In addition, both MAS and SCAT scores were significantly reduced after treatment. The changes persisted up to one week after the end of the iTBS treatment, and were not observed under the sham-iTBS condition, suggesting that iTBS may be a promising therapeutic tool for spasticity in SCI patients. The study was published on June 6, 2017, in Restorative Neurology and Neuroscience.

“Patients receiving real iTBS, compared to those receiving sham treatment, showed significant improvement,” said lead author Raffaele Nardone, MD, PhD, of Paracelsus Medical University. “In comparison with standard rTMS protocols, iTBS represents a more feasible approach because of lower stimulation intensity and shorter duration of application in each single session.”

Spasticity is a muscle control disorder caused by an imbalance between signals from the central nervous system (CNS) to the muscles. It is often found in people with cerebral palsy, traumatic brain injury (TBI), SCI, stroke, and multiple sclerosis (MS). It is characterized by increased muscle tone, overactive reflexes, involuntary movements, which may include spasms and clonus, pain, decreased functional abilities, abnormal posture, contractures, and bone and joint deformities.

Related Links:
Paracelsus Medical University
University of Verona
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.